---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-017367"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2023-05-15T23:59:59+00:00"
generated_at: "2026-06-15T00:55:12.759162+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# InspireMD announces $42.2M upfront private placement with up to $113.6M total; led by Marshall Wace

## Summary
- Gross proceeds of $42.2M upfront; additional $71.4M if milestone-driven warrants exercised in cash.
- Investors include Marshall Wace, OrbiMed, Rosalind, Nantahala, Soleus, Velan, and certain board members.
- Warrants exercisable at $1.3827/share upon FDA approvals or pivotal trial results (4 series, each ~$17.9M).
- Net proceeds to fund product/clinical development, regulatory approvals, and U.S. launch of CGuard Prime and SwitchGuard.
- Closing expected May 15, 2023; Piper Sandler, A.G.P., LifeSci Capital act as advisors.

## SEC filing metadata
- accession: 0001493152-23-017367
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2023-05-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315223017367/0001493152-23-017367-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315223017367/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-017367
- JSON: https://secwatch.observer/filing/0001493152-23-017367.json
- Plain text: https://secwatch.observer/filing/0001493152-23-017367.txt

## Key facts
- Material Agreements
  InspireMD, Inc. entered into Purchase Agreement valued at approximately $42.2 million (effective 2023-05-12).
  - Action: entry
  - Agreement: equity purchase
  - Value: approximately $42.2 million
  - Effective: 2023-05-12
  source text: On May 12, 2023, InspireMD, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000149315223017367/0001493152-23-017367-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.